Our study shows that FANCF silencing in MCF-7 and T-47D breast cancer cells increases MX sensitivity by selectively inhibiting BCRP expression through activation of p38 MAPK pathway (Fig. 4). This evidence concerns the gene MX1 and breast carcinoma.